Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 6350 | 28.555 |
09:34 ET | 7432 | 28.45 |
09:36 ET | 2067 | 28.55 |
09:38 ET | 100 | 28.5 |
09:39 ET | 1102 | 28.555 |
09:41 ET | 1185 | 28.55 |
09:43 ET | 611 | 28.6 |
09:45 ET | 8658 | 28.69 |
09:48 ET | 2400 | 28.6 |
09:50 ET | 2798 | 28.63 |
09:52 ET | 4100 | 28.7 |
09:54 ET | 1505 | 28.785 |
09:56 ET | 8953 | 28.845 |
09:57 ET | 1246 | 28.78 |
09:59 ET | 3506 | 28.77 |
10:01 ET | 2200 | 28.79 |
10:03 ET | 5768 | 28.82 |
10:06 ET | 2763 | 28.805 |
10:08 ET | 6015 | 28.745 |
10:10 ET | 7599 | 28.755 |
10:12 ET | 6950 | 28.815 |
10:14 ET | 3007 | 28.83 |
10:15 ET | 1769 | 28.83 |
10:17 ET | 4211 | 28.82 |
10:19 ET | 1768 | 28.825 |
10:21 ET | 1322 | 28.83 |
10:24 ET | 4858 | 28.82 |
10:26 ET | 1500 | 28.82 |
10:28 ET | 3088 | 28.84 |
10:30 ET | 2229 | 28.845 |
10:32 ET | 2228 | 28.86 |
10:33 ET | 1447 | 28.88 |
10:35 ET | 2416 | 28.905 |
10:37 ET | 5522 | 28.93 |
10:39 ET | 3350 | 28.875 |
10:42 ET | 2100 | 28.88 |
10:44 ET | 3377 | 28.905 |
10:46 ET | 1000 | 28.91 |
10:48 ET | 2150 | 28.93 |
10:50 ET | 2504 | 28.96 |
10:51 ET | 3239 | 28.975 |
10:53 ET | 12103 | 28.96 |
10:55 ET | 2200 | 28.945 |
10:57 ET | 1200 | 28.96 |
11:00 ET | 1534 | 28.94 |
11:02 ET | 2400 | 28.94 |
11:04 ET | 2341 | 28.93 |
11:06 ET | 13190 | 28.935 |
11:08 ET | 3450 | 28.93 |
11:09 ET | 2749 | 28.86 |
11:11 ET | 5406 | 28.865 |
11:13 ET | 2800 | 28.885 |
11:15 ET | 1412 | 28.88 |
11:18 ET | 700 | 28.88 |
11:20 ET | 2113 | 28.9 |
11:22 ET | 2825 | 28.86 |
11:24 ET | 4077 | 28.83 |
11:26 ET | 3680 | 28.815 |
11:27 ET | 2799 | 28.805 |
11:29 ET | 1292 | 28.82 |
11:31 ET | 400 | 28.82 |
11:33 ET | 1959 | 28.845 |
11:36 ET | 800 | 28.865 |
11:38 ET | 200 | 28.87 |
11:40 ET | 3646 | 28.88 |
11:42 ET | 600 | 28.875 |
11:44 ET | 2800 | 28.91 |
11:45 ET | 200 | 28.91 |
11:47 ET | 1007 | 28.885 |
11:49 ET | 11900 | 28.85 |
11:51 ET | 1427 | 28.845 |
11:54 ET | 63472 | 28.75 |
11:56 ET | 1607 | 28.765 |
11:58 ET | 1499 | 28.78 |
12:00 ET | 800 | 28.785 |
12:02 ET | 1800 | 28.78 |
12:03 ET | 500 | 28.78 |
12:05 ET | 5632 | 28.77 |
12:07 ET | 3358 | 28.765 |
12:09 ET | 3260 | 28.77 |
12:12 ET | 1200 | 28.77 |
12:14 ET | 4302 | 28.77 |
12:16 ET | 3025 | 28.78 |
12:18 ET | 3569 | 28.755 |
12:20 ET | 6139 | 28.745 |
12:21 ET | 4183 | 28.745 |
12:23 ET | 1389 | 28.76 |
12:25 ET | 4532 | 28.75 |
12:27 ET | 3762 | 28.73 |
12:30 ET | 3581 | 28.74 |
12:32 ET | 6109 | 28.74 |
12:34 ET | 3675 | 28.735 |
12:36 ET | 4395 | 28.71 |
12:38 ET | 6617 | 28.705 |
12:39 ET | 1200 | 28.705 |
12:41 ET | 2056 | 28.72 |
12:43 ET | 3700 | 28.72 |
12:45 ET | 5798 | 28.725 |
12:48 ET | 3481 | 28.72 |
12:50 ET | 633 | 28.725 |
12:52 ET | 4452 | 28.715 |
12:54 ET | 3041 | 28.73 |
12:56 ET | 3506 | 28.735 |
12:57 ET | 1400 | 28.74 |
12:59 ET | 2758 | 28.72 |
01:01 ET | 1499 | 28.72 |
01:03 ET | 2239 | 28.7 |
01:06 ET | 300 | 28.705 |
01:08 ET | 1745 | 28.71 |
01:10 ET | 3048 | 28.705 |
01:12 ET | 3595 | 28.72 |
01:14 ET | 9481 | 28.785 |
01:15 ET | 1600 | 28.79 |
01:17 ET | 2500 | 28.8 |
01:19 ET | 2212 | 28.795 |
01:21 ET | 1508 | 28.815 |
01:24 ET | 3293 | 28.815 |
01:26 ET | 700 | 28.815 |
01:28 ET | 800 | 28.82 |
01:30 ET | 200 | 28.82 |
01:32 ET | 3287 | 28.8 |
01:33 ET | 2391 | 28.8 |
01:35 ET | 1778 | 28.8 |
01:37 ET | 1568 | 28.81 |
01:39 ET | 3270 | 28.831 |
01:42 ET | 4295 | 28.885 |
01:44 ET | 2908 | 28.89 |
01:46 ET | 1259 | 28.9 |
01:48 ET | 710 | 28.9 |
01:50 ET | 4537 | 28.915 |
01:51 ET | 4069 | 28.95 |
01:53 ET | 3360 | 28.98 |
01:55 ET | 1977 | 28.975 |
01:57 ET | 2210 | 28.945 |
02:00 ET | 2212 | 28.95 |
02:02 ET | 1406 | 28.965 |
02:04 ET | 1634 | 28.965 |
02:06 ET | 2468 | 28.945 |
02:08 ET | 6878 | 28.915 |
02:09 ET | 2038 | 28.905 |
02:11 ET | 1201 | 28.89 |
02:13 ET | 1000 | 28.915 |
02:15 ET | 11345 | 28.88 |
02:18 ET | 6437 | 28.85 |
02:20 ET | 616 | 28.855 |
02:22 ET | 2557 | 28.89 |
02:24 ET | 2418 | 28.88 |
02:26 ET | 1221 | 28.87 |
02:27 ET | 647 | 28.88 |
02:29 ET | 2233 | 28.87 |
02:31 ET | 401 | 28.88 |
02:33 ET | 1283 | 28.905 |
02:36 ET | 200 | 28.905 |
02:38 ET | 1427 | 28.9 |
02:40 ET | 950 | 28.89 |
02:42 ET | 814 | 28.895 |
02:44 ET | 100 | 28.895 |
02:45 ET | 1567 | 28.88 |
02:47 ET | 2044 | 28.91 |
02:49 ET | 1822 | 28.94 |
02:51 ET | 2023 | 28.945 |
02:54 ET | 2852 | 28.95 |
02:56 ET | 507 | 28.945 |
02:58 ET | 1559 | 28.935 |
03:00 ET | 1479 | 28.92 |
03:02 ET | 2886 | 28.92 |
03:03 ET | 610 | 28.925 |
03:05 ET | 5079 | 28.9 |
03:07 ET | 2400 | 28.895 |
03:09 ET | 3864 | 28.9 |
03:12 ET | 2150 | 28.915 |
03:14 ET | 4661 | 28.915 |
03:16 ET | 1857 | 28.955 |
03:18 ET | 1704 | 28.97 |
03:20 ET | 1840 | 28.97 |
03:21 ET | 267 | 28.97 |
03:23 ET | 5020 | 28.995 |
03:25 ET | 28810 | 28.94 |
03:27 ET | 1984 | 28.95 |
03:30 ET | 564 | 28.96 |
03:32 ET | 6949 | 28.94 |
03:34 ET | 2275 | 28.945 |
03:36 ET | 1348 | 28.965 |
03:38 ET | 7101 | 28.975 |
03:39 ET | 1836 | 28.999 |
03:41 ET | 8388 | 28.985 |
03:43 ET | 4779 | 28.99 |
03:45 ET | 7776 | 28.95 |
03:48 ET | 3054 | 28.955 |
03:50 ET | 4676 | 28.985 |
03:52 ET | 10697 | 29.005 |
03:54 ET | 13408 | 29.01 |
03:56 ET | 23817 | 29.009 |
03:57 ET | 40113 | 28.995 |
03:59 ET | 304982 | 29 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.7B | 10.8x | --- |
Exelixis Inc | 7.5B | 22.7x | -21.77% |
PTC Therapeutics Inc | 2.8B | -5.8x | --- |
Medpace Holdings Inc | 10.3B | 31.7x | +35.10% |
Ionis Pharmaceuticals Inc | 6.2B | -15.6x | --- |
P3 Health Partners Inc | 139.2M | -0.7x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7B |
---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 164.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $2.67 |
Book Value | $7.20 |
P/E Ratio | 10.8x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 9.3x |
Operating Margin | 24.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.